FT-6876, a Potent and Selective Inhibitor of CBP/p300, is Active in Preclinical Models of Androgen Receptor-Positive Breast Cancer. - Caligiuri, Maureen; Williams, Grace L.; Castro, Jennifer; Battalagine, Linda; Wilker, Erik; Yao, Lili; Schiller, Shawn; Toms, Angela; Li, Ping; Pardo, Eneida; Graves, Bradford; Azofeifa, Joey; et al. (Targeted Oncology, 2023)